Back to mobile site

More on ALLR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-31.6% Growth)
- Ratings (5.0 Score)

Upcoming Events

- Earnings (11/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Allarity Therapeutics (NQ:ALLR)
Delayed: 1.42 --0 (-0%)
Prev. Close $1.42  
Open$1.42 
52 Wk High$ 
52 Wk Low$ 
Day High$1.42 
Day Low$1.42 
P/E N/A  
EPS$ 
Volume601 


Aug 14, 2026 04:39 PM Form 8-K Allarity Therapeutics, For: Aug 14
Aug 14, 2026 08:03 AM Form 10-Q Allarity Therapeutics, For: Jun 30
Aug 14, 2026 08:00 AM Allarity reports Q2 2026 results, completes stenoparib manufacturing
Aug 14, 2026 08:00 AM Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
Jul 7, 2026 08:03 AM Allarity gets CLIA certification for its Denmark lab
Jul 7, 2026 08:00 AM Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration
Jul 1, 2026 08:06 AM Form 8-K Allarity Therapeutics, For: Jun 26
Jun 30, 2026 08:01 AM Allarity gets U.S. patent for stenoparib companion diagnostic
Jun 30, 2026 08:00 AM Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic
Jun 22, 2026 08:10 AM Form 8-K Allarity Therapeutics, For: Jun 18
View All Articles

Entities mentioned with ALLR

View All Entities